Corazón (debilidad)

Alpha-lipoic acid (ALA) is an antioxidant with clinical evidence for reducing neuropathic pain. A 2009 study found ALA (600 mg/day) plus gamma-linolenic acid provided significant improvement in sciatica pain over 6 weeks. A 2024 randomized clinical trial in young patients with discogenic sciatica used ALA in combination with other nutrients and found meaningful pain reduction.

Benfotiamine has been used clinically in Europe since the 1960s for sciatica and painful nerve conditions, including as a registered pharmaceutical in Germany. Its use for sciatica is based on its established efficacy in peripheral neuropathic pain and its ability to reduce nerve inflammation and AGE-mediated nerve damage.

Boswellia serrata resin contains boswellic acids that inhibit 5-lipoxygenase, reducing leukotriene-mediated inflammation relevant to nerve root irritation in sciatica. A 2025 prospective multicenter observational study of Boswellia serrata as add-on therapy in 103 chronic low-back and neuropathic pain patients showed significant reductions in pain scores. A double-blind placebo-controlled trial of a Boswellia-turmeric combination significantly reduced chronic lower back pain.

Boswellic acids are the active constituents of Boswellia serrata responsible for 5-lipoxygenase inhibition and anti-inflammatory effects studied in low back pain and neuropathic conditions. Clinical studies using standardized boswellic acid extracts have demonstrated reductions in chronic low back pain and neuropathic pain scores.

Capsaicin, the active pungent compound in Capsicum peppers, acts on TRPV1 receptors on nociceptive fibers to desensitize pain signaling. Topical capsaicin is FDA-recognized as an OTC counterirritant for neuropathic pain and has been studied in sciatica-related neuropathic pain models. High-concentration capsaicin patch (8%) is used clinically for peripheral neuropathic pain.

Clinical evidence supports trypsin:chymotrypsin in sciatica secondary to intervertebral disc protrusion, where it is proposed to decrease inflammatory edema around compressed nerve roots. A PubMed-indexed clinical report (Chymoral tablets in sciatica, 1971) and subsequent reviews confirm this application. The anti-inflammatory and anti-edematous mechanisms are the primary proposed modes of action.

Curcumin, the primary bioactive compound in turmeric, has been studied in sciatic nerve injury models and low back pain clinical trials. It inhibits NF-κB, COX-2, TNF-α, and IL-6, reduces neuropathic allodynia in animal models, and promotes sciatic nerve regeneration. A randomized clinical trial combining curcumin with Boswellia significantly reduced chronic lower back pain versus placebo.

Devil's Claw (Harpagophytum procumbens) has been evaluated in multiple clinical trials for musculoskeletal pain including low back pain and sciatica. Its iridoid glycoside harpagoside exerts anti-inflammatory and analgesic effects. A 2007 Cochrane review found moderate evidence it reduces low back pain more effectively than placebo, with efficacy comparable to some NSAIDs in certain trials.

Ginger root contains gingerols and shogaols with anti-inflammatory and antinociceptive properties relevant to sciatica. Pre-clinical studies show ginger polyphenols modulate neuroinflammation and gut-brain axis in spinal nerve ligation neuropathic pain models. A registered randomized placebo-controlled trial is currently evaluating ginger root extract (2000 mg/day) specifically in chronic sciatica patients.

Magnesium deficiency is linked to neuropathic pain and muscle spasm that can exacerbate sciatica. Magnesium supplementation has been associated with reduced muscle inflexibility and discomfort in sciatica patients. It acts as an NMDA receptor antagonist, blocking central sensitization relevant to chronic sciatic pain.

Omega-3 fatty acids (EPA and DHA) exert potent anti-inflammatory effects by shifting eicosanoid production away from pro-inflammatory mediators, relevant to nerve root inflammation in sciatica. A 2009 clinical study found omega-3 fatty acids (as GLA, 360 mg/day) combined with alpha-lipoic acid significantly improved sciatica pain over 6 weeks. Multiple authoritative sources identify omega-3s as a key supplement for sciatic pain.

Trypsin:chymotrypsin combination preparations have clinical trial evidence specifically for sciatica. The PMC review (Shah & Mital, 2018) states that efficacy in sciatica is corroborated by a substantial and largely consistent body of evidence. The mechanism involves reduction of inflammation and edema around the affected nerve root.

Turmeric's active compound curcumin has demonstrated antinociceptive and neuroprotective effects in sciatic nerve injury models and has been studied for low back pain in clinical trials. Pre-clinical studies show curcumin reduces allodynia and hyperalgesia in sciatic nerve constriction models. A randomized double-blind placebo-controlled clinical trial found a Boswellia-curcumin combination significantly relieved chronic lower back pain.

Vitamin B12 (cobalamin) is essential for myelin sheath formation and maintenance, directly relevant to sciatic nerve health. Deficiency causes peripheral neuropathy that can mimic or worsen sciatica. Supplementation has shown benefit in low back pain with neuropathic features and is consistently identified as among the most effective nutrients for sciatic nerve repair.

Vitamin D deficiency is strongly linked to musculoskeletal and neuropathic pain including sciatica. Vitamin D reduces nerve inflammation, supports calcium absorption for cartilage and bone health, and modulates immune responses relevant to nerve root irritation. Multiple authoritative clinical reviews identify vitamin D as a key nutrient in sciatica management.

Vitamin D3 (cholecalciferol) is the bioactive supplemental form of vitamin D, identified in multiple authoritative clinical reviews as a key nutrient for sciatic nerve pain. It reduces neuroinflammation, supports myelin health, and addresses deficiency linked to worsening sciatica. A randomized clinical trial used D3 in a combination treatment for discogenic sciatica.

White willow bark contains salicin, which is metabolized to salicylic acid, providing analgesic and anti-inflammatory effects via COX inhibition. A 4-week double-blind placebo-controlled study in 210 patients with chronic back pain showed that 240 mg salicin/day resulted in 39% becoming pain-free versus 6% on placebo. A systematic review found moderate evidence for willow bark extract in low back pain.

Ashwagandha (Withania somnifera) is a core Ayurvedic herb traditionally indicated for sciatica as a Vata-pacifying adaptogen. It is used to reduce inflammation and irritation in sciatic nerves, strengthen back muscles and spine, and rejuvenate neural tissue. Scientific evidence for sciatica is absent in clinical trials; evidence derives from Ayurvedic textual sources and traditional practice.

Black spruce is listed in aromatherapy references for sciatica, together with arthritis and rheumatism, based on its analgesic, antispasmodic, and anti-inflammatory properties. This is a traditional aromatherapy use without clinical trial support.

Capsicum has a documented traditional use for sciatica and other radicular pain syndromes, applied topically as a counterirritant. The pharmacological rationale is consistent with its established use in neuropathic and musculoskeletal pain, though controlled clinical trials specifically for sciatica are lacking.

Guggul has been used in Ayurveda for sciatica (Gridhrasi), a Vata-predominant disorder. Its Vatahara (Vata-pacifying) and anti-inflammatory properties are the basis of this traditional use. No human clinical trials for guggul in sciatica are available.

Horseradish has a documented traditional use as a topical rubefacient for sciatica. It was applied as a poultice to the affected area to increase local circulation and provide counter-irritant pain relief. The Drugs.com monograph and classical herbalists (Culpepper, 17th century) specifically name sciatica as an indication. No clinical trials exist.

Boswellia serrata is listed in traditional Ayurvedic medicine for nerve-related pain and musculoskeletal conditions including sciatica. Its 5-LOX inhibition and analgesic properties provide mechanistic plausibility. However, no specific human clinical trials in sciatica have been identified in the peer-reviewed literature.

Sciatica is listed as a traditional indication for prickly ash in multiple professional herbal monographs, based on its classification as a circulatory stimulant, analgesic, and nerve tonic. It is used in traditional herbalism for nerve pain radiating from the lower back. No clinical trial evidence supports this use.

Rose hip has documented traditional use for back and leg pain including sciatica in European folk medicine and is specifically listed for sciatica and back/leg pain in RxList and Restorative Medicine's herbal monograph. The proposed basis is rose hip's anti-inflammatory properties reducing nerve root inflammation, consistent with its wider anti-inflammatory pharmacology.

Rosemary has documented traditional use for pain along the sciatic nerve in European folk medicine and is listed among its traditional indications in pharmaceutical references. No human clinical trials specifically in sciatica have been conducted.

Sciatica is listed among musculoskeletal and connective tissue conditions captured in post-marketing surveillance studies of willow bark extract (including cases of sciatica), and salicin-containing preparations have a traditional role in radicular and back-related pain. No dedicated RCT targeting sciatica as a primary endpoint exists.

Sciatica is listed as a traditional indication for Solomon's seal in contemporary Western herbal practice, drawing on the herb's established role in back pain, spinal disc, and nerve-adjacent connective tissue support. Documentation comes from contemporary herbal monographs rather than historical texts.

St. John's Wort (Hypericum perforatum) has been used traditionally in European herbal medicine as a nerve tonic specifically indicated for sciatica and neuralgia, both internally and topically. Modern herbalists list it as a nervine trophorestorative. While in vitro and animal studies support its anti-inflammatory properties via hyperforin and hypericin, clinical evidence specific to sciatica is lacking.

Tribulus terrestris (Gokshura) is used in Ayurvedic and Unani medicine as a nervine, analgesic, and rejuvenative tonic specifically indicated for sciatica. Traditional practice involves milk decoction with dried ginger to relieve sciatic and back pain. Scientific evidence specific to sciatica is absent; the indication is based on classical Ayurvedic texts.

Valerian root has been used traditionally as a muscle relaxant and nerve analgesic specifically indicated for sciatica in European and Ayurvedic herbal medicine. It contains valerenic acid and valepotriates that modulate GABA receptors and exert antispasmodic effects. Animal research supports its ability to reduce neuropathic pain behaviors; human clinical evidence for sciatica specifically remains limited.

Wintergreen oil is traditionally listed in herbal formularies for sciatica, with Christopher Hobbs' herbal therapeutics database and historical texts citing its external use for nerve pain. Methyl salicylate is FDA-labeled for nerve pain relief in topical OTC products. Clinical trial evidence specific to sciatica is absent.